Novadip Biosciences
Mont-Saint-Guibert, Walloon Region, Belgium · Biotechnology, Health Care, Medical
Novadip Biosciences is a biopharmaceutical company founded to design, develop and bring to the market innovative stem cell-based therapies for regenerative medicine. The first proprietary cellular therapy of Novadip Biosciences is a totally differentiated and 3D osteogenic scaffold-free structure which provide innovative treatments for severe bone healing disorders. Their lead product NVD-001 int
Key facts
- Headquarters
- Mont-Saint-Guibert, Walloon Region, Belgium
- Employees
- 58
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.novadip.com
- Company page
Recent activity at Novadip Biosciences
Novadip Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Convertible Note | $10.4M |
| Nov 2022 | Funding Round | $40.0M |
Leadership
- Denis Dufrane, CEO & Co-founder
- Anne -Sophie Jacqmin, Finance & Admin Director
- Gaetane, Corporate Vice President Quality
- Soumya, Chief Financial Officer
Verified email and direct lines for Novadip Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Novadip Biosciences in the news
- Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million - Business Wire (Nov 03, 2022)
- Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs - PR Newswire (Dec 05, 2023)
- NOVADIP BIOSCIENCES Appoints Jeff Abbey as CEO - PR Newswire (Dec 12, 2018)
Companies similar to Novadip Biosciences
- N-Power Medicine · Biotechnology, Health Care, Medical, Therapeutics
- Scipher Medicine · Biotechnology, Health Care, Medical, Therapeutics
- AvenCell Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Omnio · Biotechnology, Health Care, Medical, Therapeutics
- Abivax · Biotechnology, Health Care, Medical, Therapeutics
About Novadip Biosciences: questions and answers
What does Novadip Biosciences do?
Novadip Biosciences is a biopharmaceutical company founded to design, develop and bring to the market innovative stem cell-based therapies for regenerative medicine. The first proprietary cellular therapy of Novadip Biosciences is a totally differentiated and 3D osteogenic scaffold-free structure which provide innovative treatments for severe bone healing disorders. Their lead product NVD-001 int
Where is Novadip Biosciences headquartered?
Novadip Biosciences is headquartered in Mont-Saint-Guibert, Walloon Region, Belgium.
How many employees does Novadip Biosciences have?
Novadip Biosciences has about 58 employees.
Has Novadip Biosciences raised funding?
Yes. Fundz has recorded 2 funding events for Novadip Biosciences. The most recent, Convertible Note of $10.4M, was in Sep 2026.
Who leads Novadip Biosciences?
Denis Dufrane is a CEO & Co-founder at Novadip Biosciences.
What is the latest news on Novadip Biosciences?
On Sep 21, 2026, Novadip Biosciences closes a €10.4M funding round led by New Science Ventures. The funds will advance its NVD003 therapy through final clinical development stages.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy